Home › Entities › clinical_trial › Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection

Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection

clinical trial
MedicalStudy clinical_trial Q87775009
Press Enter · cited answer in seconds

Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection

Summary

Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection is a clinical trial[1].

Key Facts

  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection is in the country of United States[2].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's instance of is recorded as clinical trial[3].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's start time is recorded as +2020-03-16T00:00:00Z[4].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's end time is recorded as +2021-11-22T00:00:00Z[5].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's sponsor is recorded as National Institute of Allergy and Infectious Diseases[6].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's main subject is recorded as immunogenicity[7].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's main subject is recorded as COVID-19[8].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's main subject is recorded as safety[9].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's main subject is recorded as SARS-CoV-2[10].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's main subject is recorded as mRNA-1273 vaccine[11].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's PMC publication ID is recorded as 7556339[12].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's number of participants is recorded as {'unit': '1', 'amount': '+120'}[13].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's title is recorded as Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection[14].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's title is recorded as Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)[15].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q24564698', 'amount': '+18'}[16].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's ClinicalTrials.gov ID is recorded as NCT04283461[17].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q24564698', 'amount': '+99'}[18].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's research intervention is recorded as mRNA-1273 vaccine[19].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's clinical trial phase is recorded as phase I clinical trial[20].
  • Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection's study type is recorded as interventional study[21].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . covid-19tracker.milkeninstitute.org. Retrieved . covid-19tracker.milkeninstitute.org. Provenance: wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . covid-19tracker.milkeninstitute.org. Retrieved . covid-19tracker.milkeninstitute.org. Provenance: wikidata.org.
  19. [20] ↑ . wikidata.org.
  20. [21] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection. Retrieved May 3, 2026, from https://4ort.xyz/entity/safety-and-immunogenicity-study-of-2019-ncov-vaccine-mrna-1273-to-prevent-sars-cov-2-infection
MLA “Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/safety-and-immunogenicity-study-of-2019-ncov-vaccine-mrna-1273-to-prevent-sars-cov-2-infection.
BibTeX @misc{4ortxyz_safety-and-immunogenicity-study-of-2019-ncov-vaccine-mrna-1273-to-prevent-sars-cov-2-infection_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection}}, year = {2026}, url = {https://4ort.xyz/entity/safety-and-immunogenicity-study-of-2019-ncov-vaccine-mrna-1273-to-prevent-sars-cov-2-infection}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection — https://4ort.xyz/entity/safety-and-immunogenicity-study-of-2019-ncov-vaccine-mrna-1273-to-prevent-sars-cov-2-infection (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/safety-and-immunogenicity-study-of-2019-ncov-vaccine-mrna-1273-to-prevent-sars-cov-2-infection · Last refreshed: